Abstract:The present work highlights manganese nitrogen dual-doped carbon quantum dots as a novel pH-sensitive drug delivery system for the delivery of methotrexate targeted to cancer cells, along with the simultaneous real-time monitoring of cellular uptake and drug delivery using fluorescence imaging. Briefly, methotrexate was conjugated with the as-prepared quantum dots to form a nano drug-delivery system through non-covalent interactions. The developed material demonstrated drug loading efficiency of ∼91 % and a very efficient (∼80 %) pH-responsive drug release at pH 5.5. The cytotoxic properties of the developed nano-platform viz. manganese, nitrogen dual-doped carbon quantum dots, and methotrexate conjugated manganese nitrogen dual-doped carbon quantum dot complex were evaluated in cancer cells (HeLa) and healthy human cells (L929). The conjugated complex demonstrated excellent biocompatibility, high cellular uptake, and a substantial drug release. Healthy human cells were largely unaffected when incubated with both the MTX-conjugated Mn-, N-CQD and the free drug. Additionally, in vitro, the fluorescence bio-imaging potential of the developed nano-platform was also assessed, where the unconjugated (free) quantum dots exhibited better blue fluorescence imaging potential compared to that of conjugated complex, which can be attributed to fluorescence quenching due to the presence of methotrexate. This study highlights the manganese nitrogen dual-doped carbon quantum dots capable of pH-responsive methotrexate drug delivery selective to cancer cells. The combination of drug delivery and fluorescence imaging creates a strong platform for targeted therapy, allowing very precise drug release while accessing non-invasive monitoring of therapeutic response. This method holds great promise for advancing cancer treatment strategies, with the potential for increased efficacy and decreased side effects.

Folic acid-conjugated magnetic mesoporous silica nanoparticles loaded with quercetin: a theranostic approach for cancer management

Folate receptor targeted chitosan and polydopamine coated mesoporous silica nanoparticles for photothermal therapy and drug delivery

Iron oxide nanoparticle encapsulated; folic acid tethered dual metal organic framework-based nanocomposite for MRI and selective targeting of folate receptor expressing breast cancer cells

Folate receptor-targeted multimodal fluorescence mesosilica nanoparticles for imaging, delivery palladium complex and in vitro G-quadruplex DNA interaction

Multifunctional Mesoporous Silica Nanoparticles for Cancer-Targeted and Controlled Drug Delivery

Towards Magnetic-Enhanced Cellular Uptake, MRI and Chemotherapeutics Delivery by Magnetic Mesoporous Silica Nanoparticles

Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy

Preparation of Magnetic Iron Oxide Incorporated Mesoporous Silica Hybrid Composites for pH and Temperature-Sensitive Drug Delivery

Folate encapsulation in PEG-diamine grafted mesoporous Fe3O4 nanoparticles for hyperthermia and in vitro assessment

Quercetin Nanoparticles- A Promising Approach to Cancer Treatment: A Review

Magnetic iron oxide nanoparticles@lecithin/poly (l-lactic acid) microspheres for targeted drug release in cancer therapy

Folic Acid-Targeted Polydopamine-Based Surface Modification of Mesoporous Silica Nanoparticles As Delivery Vehicles for Cancer Therapy

The Intracellular Controlled Release from Bioresponsive Mesoporous Silica with Folate As Both Targeting and Capping Agent

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Methotrexate-loaded manganese nitrogen dual-doped carbon quantum dots as targeted nano drug-delivery system for potential use in cancer theranostics

Innovative chitosan-polyacrylic acid-MoS 2 nanocomposite for enhanced and pH-responsive quercetin delivery

Targeted Drug Delivery of Quercetin to Breast Cancer Cells Using a Modified SBA-15 Mesoporous Nanostructure

Amidoxime functionalized mesoporous silica nanoparticles for pH-responsive delivery of anticancer drug

A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe3O4 nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer

Quercetin-Loaded Luminescent Hydroxyapatite Nanoparticles for Theranostic Application in Monolayer and Spheroid Cultures of Cervical Cancer Cell Line In Vitro

Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.